摘要
目的:探讨Ubc9在人肺癌组织中的表达及临床意义。方法:应用免疫组织化学法和实时荧光定量PCR(real time quantitative PCR,RT-qPCR)法检测143例肺癌组织及同源非癌变组织中Ubc9的表达情况,并对临床病理资料进行分析。结果:与癌旁组织相比,Ubc9在肺癌组织中呈高表达(P<0.05),Ubc9的表达与年龄、淋巴结转移、TNM分期及预后密切相关,有统计学意义(P<0.05);而与性别、病理学类型、组织分化程度无关。结论:小细胞肺癌、肺鳞癌和肺腺癌中均有Ubc9阳性表达,均高于正常的肺组织,并且与肺癌淋巴结转移程度相关,提示Ubc9可能与肺癌细胞的转移特性有关。
Objective:To investigate the expressions and clinical significance of Ubc9 in human lung cancer and its prognostic significance. Methods:The expression of Ubc9 in 143 lung cancer specimens and adjacent normal tis-sues were detected by immunohistochemical( IHC)and real time quantitative PCR method. The relationship between the Ubc9 expression and pathological data,prognostic factors were analyzed. Results:Compared with adjacent normal tissues,the expression of Ubc9 mRNA in cancerous tissues was higher(P〈0. 05). The expression of Ubc9 was statis-tically significantly correlated with age,lymph nodes metastasis,clinical stage and prognosis(P〈0. 05),but was not correlated with sex,histological type,differential(P〉0. 05). Conclusion:The high expressions of Ubc9 in lung canc-er was related to lymph nodes metastasis,and may be associated with the metastasis of lung cancer.
出处
《现代肿瘤医学》
CAS
2014年第10期2343-2346,共4页
Journal of Modern Oncology
基金
辽宁省博士科研启动基金计划资助项目(编号:20141036)
关键词
UBC9
肺癌
转移
Ubc9
lung cancer
metastasis